GB1401298A - Ligands bonded to enzymes - Google Patents

Ligands bonded to enzymes

Info

Publication number
GB1401298A
GB1401298A GB345175A GB345175A GB1401298A GB 1401298 A GB1401298 A GB 1401298A GB 345175 A GB345175 A GB 345175A GB 345175 A GB345175 A GB 345175A GB 1401298 A GB1401298 A GB 1401298A
Authority
GB
United Kingdom
Prior art keywords
morphine
amylase
phenobarbital
carboxymethyl
meperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB345175A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYNTEX ENERGY RES
VARIAN ENERGY
Original Assignee
SYNTEX ENERGY RES
VARIAN ENERGY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYNTEX ENERGY RES, VARIAN ENERGY filed Critical SYNTEX ENERGY RES
Publication of GB1401298A publication Critical patent/GB1401298A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB345175A 1971-05-14 1972-05-15 Ligands bonded to enzymes Expired GB1401298A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (1)

Publication Number Publication Date
GB1401298A true GB1401298A (en) 1975-07-16

Family

ID=22504809

Family Applications (2)

Application Number Title Priority Date Filing Date
GB345175A Expired GB1401298A (en) 1971-05-14 1972-05-15 Ligands bonded to enzymes
GB2277872A Expired GB1401297A (en) 1971-05-14 1972-05-15 Enzyme aplification assay

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2277872A Expired GB1401297A (en) 1971-05-14 1972-05-15 Enzyme aplification assay

Country Status (12)

Country Link
JP (1) JPS5327763B1 (it)
BR (1) BR7202989D0 (it)
CA (1) CA1003770A (it)
CH (1) CH553410A (it)
DE (1) DE2223385C3 (it)
ES (1) ES402720A1 (it)
FR (1) FR2139505A5 (it)
GB (2) GB1401298A (it)
IL (1) IL39323A (it)
IT (1) IT972332B (it)
NL (1) NL170564C (it)
SE (1) SE403190B (it)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
ATE17048T1 (de) * 1982-05-26 1986-01-15 Boots Celltech Diagnostics Immunoassay.
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (it) * 1984-12-21 1987-09-16 Sclavo Spa Metodo immunoenzimatico per la determinazione di analiti e composizione adatti allo scopo
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (en) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagent for meprobamate

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay
EP0040224A1 (en) * 1979-11-19 1981-11-25 The Prince Charles Hospital Development Centre Trust An improved method of non homogenous enzyme immunoassay
EP0040224A4 (en) * 1979-11-19 1982-09-09 Prince Charles Hospital Dev Ct IMPROVED PROCESS FOR IMMUNOLOGICAL ANALYSIS OF NON-HOMOGENOUS ENZYMES.
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5391478A (en) * 1988-05-10 1995-02-21 E. I. Du Pont De Nemours And Company Assay device and immunoassay

Also Published As

Publication number Publication date
BR7202989D0 (pt) 1973-11-01
GB1401297A (en) 1975-07-16
IL39323A0 (en) 1972-06-28
CA1003770A (en) 1977-01-18
JPS5327763B1 (it) 1978-08-10
DE2223385A1 (de) 1973-01-04
NL7206434A (it) 1972-11-16
SE403190B (sv) 1978-07-31
DE2223385B2 (de) 1979-02-22
IT972332B (it) 1974-05-20
FR2139505A5 (it) 1973-01-05
CH553410A (fr) 1974-08-30
DE2223385C3 (de) 1984-10-25
NL170564C (nl) 1982-11-16
NL170564B (nl) 1982-06-16
IL39323A (en) 1975-08-31
ES402720A1 (es) 1976-12-01

Similar Documents

Publication Publication Date Title
GB1401298A (en) Ligands bonded to enzymes
GB1433783A (en) Process for the detection and determination of haptens
GB1498081A (en) Covalently bound biological substances to plastic materials and use in radioassay
AU7262691A (en) Anabolic activity modulator and uses thereof
SE8200715L (sv) Reduktion av pyrogenhalt
ES452916A1 (es) Procedimiento para determinar la actividad de creantincina- sa-mb en una muestra de liquido corporal.
GB1451669A (en) Protein staining
GB1426068A (en) Method and test kit for the analysis of isoenzyme patterns
GB1409753A (en) Method in the quantitative and qualitative determination of molecules having antigenic properties by immunoelectrophoresis
ES8205063A1 (es) Procedimiento para la determinacion cuantitativa, inmunologica de enzimas, especialmente de las isoenzinas de la fosfa- tasa acida y alcalina en liquido corporales.
NL7705411A (nl) Analytische of klinische derivaten, gemerkte derivaten en werkwijze voor de analyse van deze derivaten.
GB1512052A (en) Method for the detection of antibodies
Erwin et al. Mechanism of stimulation of ornithine decarboxylase activity in transformed mouse fibroblasts
NO172708C (no) Fremgangsmaate for omdannelse av stabilt glucohemoglobin til glucitollysin-hemoglobin, mengdebestemmelse av stabilt glucohemoglobin, samt diagnostisk system for utfoerelse av mengdebestemmelsen
GB1462165A (en) Radioimmune assay method for detection of gonorrhea antibodies
NZ191337A (en) Diagnostic agent for detection of antimitochondrial and antinuclear antibodies hypernephroma cells
JPH05500001U (it)
GB1522567A (en) Reagent and method for thyroxine binding globulin assay
EP0161107A3 (en) Immunometric method for the determination of a hapten
AU527196B2 (en) Enzymatic method for detecting cancer in mammalian tissue
DE69214116D1 (de) In vitro Analyse von Molekülen an ihrer Produktionsstelle durch die Zellkultur
EP0278116A3 (en) A method for immunoassay and kit therefor
ATE144836T1 (de) System zum nachweis von nikotin und/oder nikotinmetaboliten
PH21459A (en) Process for assaying atl virus antibody and reagent therefor
GB1369582A (en) Specific antiserum and method for radioimmunoassay of human chorionic gonadotropin

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years